Hilary Tindle, MD, MPH, associate professor of medicine, Vanderbilt University, discusses the nicotine metabolite ratio (NMR) is and how it's used to help identify vulnerable individuals for lung cancer and heart disease.
The nicotine metabolite ratio (NMR) is a genetically informed biomarker that shows how nicotine is broken down by the body and varies across individuals, says Hilary Tindle, MD, MPH, associate profesor of medicine, Vanderbilt University.
Transcript
What is the NMR and how does faster metabolism contribute to a “high-risk” endophenotype?
The nicotine metabolite ratio is a genetically informed biomarker. And all it is, is the ratio or fraction of 2 breakdown products of nicotine. Nicotine in a cigarette is broken down by the liver, and nicotine has a very short half-life of only about 2 hours. But that varies a lot according to a person's genetic makeup. People who tend to break down nicotine faster are heavier smokers, they tend to smoke more, they have more difficulty quitting; therefore, they smoke for more years of their life. And therefore, they are at higher risk of smoking-related diseases, such as lung cancer and heart disease.
The nicotine metabolite ratio can be measured in blood, saliva, or even urine by a doctor. It's used in the hospital, for example, before a surgery to verify if an individual is continuing to smoke or has successfully quit smoking—but this ratio is very important for quitting. So again, people who have a higher nicotine metabolite ratio, 0.31 or higher is a commonly used cut off, those folks probably have a harder time quitting and they may even need different medication.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies
August 13th 2025The treatment of pediatric obstructive sleep apnea syndrome is moving toward a personalized, multidisciplinary approach that combines surgical options with a growing number of nonsurgical alternatives, to better address the unique needs of each child.
Read More
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More